COMMUNIQUÉS West-GlobeNewswire

Adamis Pharmaceuticals Submits New Drug Application to FDA for Its Naloxone Pre-Filled Syringe
31/12/2018
SAN DIEGO, Dec. 31, 2018 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration for its naloxone pre [...]
U.S. Food and Drug Administration Approves Portola Pharmaceuticals’ Prior Approval Supplement for Andexxa® Generation 2 Manufacturing Process
31/12/2018
– Expands Patient Access to Andexxa, the First and Only Antidote for Reversal of the Factor Xa Inhibitors Rivaroxaban or Apixaban – – Full Commercial Launch to Begin January 2019 – SOUTH SAN FRANCISCO, Calif., Dec. 31, [...]
Green Growth Brands Reaffirms Commitment to Takeover Aphria Inc.
31/12/2018
Welcomes early expressions of interest from a growing number of frustrated Aphria shareholders who want a way out of a failed investment Offer valued at C$11.00 per Aphria share represents significant and compelling [...]
Merus annonce les résultats financiers du troisième trimestre 2018 et fait le point sur son activité
31/12/2018
Jalons cliniques des quatre principaux programmes Biclonics® prévus en 2019 Les liquidités devraient être suffisantes pour financer les activités du deuxième trimestre 2021 UTRECHT, Pays-Bas, 31 déc. 2018 (GLOBE [...]
Alder BioPharmaceuticals® to Present at the 37th Annual J.P. Morgan Healthcare Conference
31/12/2018
BOTHELL, Wash., Dec. 31, 2018 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]
CLS Holdings USA, Inc. Issues Year End Review Letter
31/12/2018
LAS VEGAS, Dec. 31, 2018 (GLOBE NEWSWIRE) -- CLS Holdings USA, Inc. (OTCQB: CLSH) “CLS,” a diversified cannabis company operating as Cannabis Life Sciences and an integrated cannabis producer and retailer in Nevada [...]
Acasti Pharma Announces TRILOGY Phase 3 Trials of CaPre® in Patients with Severe Hypertriglyceridemia Has Now Exceeded 65% Randomization, and More Than 100 Patients (>20%) Have Completed Their 6 Month Treatment Plan
31/12/2018
LAVAL, Québec, Dec. 31, 2018 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of [...]
Onconova to Meet Investors and Potential Partners at China Focus and the 37th Annual J.P. Morgan Healthcare Conferences in San Francisco
31/12/2018
NEWTOWN, Pa., Dec. 31, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with a primary [...]
Geron Announces New Board Leadership Structure
31/12/2018
CEO John A. Scarlett Appointed Chairman Karin Eastham Appointed Lead Independent Director MENLO PARK, Calif., Dec. 31, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced changes to the leadership [...]
Peter D. Meldrum (1947-2018)
31/12/2018
Myriad Salutes the Life and Achievements of Its Co-Founder SALT LAKE CITY, Dec. 31, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN) today announced that the company’s former CEO Peter Durkee Meldrum, age [...]
Chief Medical Director Kari Syrjänen will retire from Biohit Oyj
31/12/2018
Biohit Oyj 31.12.2018 12:00 Biohit’s management team member Chief Medical Director Kari Syrjänen will retire as planned 31 st of December 2018. Kari Syrjänen has been employed by Biohit since 2013. ”I would like to [...]
GW Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference
31/12/2018
LONDON and CARLSBAD, Calif., Dec. 31, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), a biopharmaceutical company focused on discovering, developing and commercializing [...]
Imprimis Pharmaceuticals, Inc. Completes Name Change to Harrow Health, Inc.
31/12/2018
Harrow Health, Inc. Name Reflects the Company’s Commitment to the Future of Healthcare SAN DIEGO, Dec. 31, 2018 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (formerly known as Imprimis Pharmaceuticals, Inc.) (NASDAQ: IMMY) [...]
Eve & Co Announces First Shipment of Dried Cannabis Product and Files Financial Results for the Three and Twelve Month Periods Ended October 31, 2018
31/12/2018
TORONTO, Dec. 31, 2018 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (the “Company” or “Eve & Co”) (TSXV: EVE; OTCQB: EEVVF) is pleased to announce that it has completed its first shipment of dried cannabis product [...]
Arrayit Corporation Announces Chief Executive Officer Letter to Shareholders
31/12/2018
Sunnyvale, Dec. 31, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC ), a life sciences and personalized medicine company, announces a letter to shareholders from Arrayit Chief Executive Officer Rene Schena. The [...]
Terveystalo Plc: Terveystalo appoints Petri Bono as Chief Medical Officer
31/12/2018
Terveystalo Plc Stock Exchange release 31 December 2018 at 11:45 a.m. EET Petri Bono, born 1970, M.D., Ph.D., has been appointed as Chief Medical Officer as of 1 February 2019. He becomes a member of the Terveystalo [...]
Rule 2.9 Announcement
31/12/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 31 December 2018 [...]
Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program
31/12/2018
Company Release no. 24/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 31 December 2018 Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program Today, the Board of Directors of Veloxis [...]
Adamis Pharmaceuticals Submits New Drug Application to FDA for Its Tadalafil Sublingual Tablet
29/12/2018
SAN DIEGO, Dec. 28, 2018 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its fast- [...]

Pages